HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A founder mutation in the gamma-sarcoglycan gene of gypsies possibly predating their migration out of India.

Abstract
We investigated the molecular basis of a severe form of early onset autosomal recessive muscular dystrophy with sarcoglycan (SG) deficiency in seven large Gypsy families living in different parts of Western Europe and apparently not closely related. They were linked to the LGMD2C locus (13q12) suggesting a primary defect in the gamma-SG gene coding for the 35 kDa dystrophin-associated glycoprotein. All of the 18 investigated patients were homozygous for the same G-->A transition in codon 283 producing the replacement of a conserved cysteine of the extra-cellular domain of the protein by a tyrosine. All affected chromosomes in homozygous and heterozygous relatives carried the same allele 5 of the intragenic marker D13S232. Flanking markers were studied to delineate a common ancestral haplotype, the size of which was used to compute the date of the founding mutation. We found evidence that the mutation occurred between 60 and 200 generations ago, therefore possibly predating the commonly accepted date of migration of the Gypsy ancestors out of India.
AuthorsF Piccolo, M Jeanpierre, F Leturcq, C Dodé, K Azibi, A Toutain, L Merlini, L Jarre, C Navarro, R Krishnamoorthy, F M Tomé, J A Urtizberea, J S Beckmann, K P Campbell, J C Kaplan
JournalHuman molecular genetics (Hum Mol Genet) Vol. 5 Issue 12 Pg. 2019-22 (Dec 1996) ISSN: 0964-6906 [Print] England
PMID8968757 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Cytoskeletal Proteins
  • Membrane Glycoproteins
  • Sarcoglycans
Topics
  • Biomarkers
  • Cytoskeletal Proteins (genetics)
  • Europe (epidemiology)
  • Genetics, Population
  • Humans
  • India (ethnology)
  • Membrane Glycoproteins (genetics)
  • Muscular Dystrophies (ethnology, genetics)
  • Roma
  • Sarcoglycans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: